BioRelix Inc.
www.biorelix.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From BioRelix Inc.
Restructuring for Success: Shifting Biotech Strategies
During a panel discussion at Elsevier Business Intelligence’s Therapeutic Area Partnerships conference in Boston in December 2011, experienced investors and biotech executives drew lessons from difficult restructurings and successful transitions.
Recent Financings of Private Companies (10/2011)
Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.
Deals Shaping the Medical Industry (11/2010)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions
BioRelix and Merck & Co in antibacterial collaboration
BioRelix has entered into a research collaboration with Merck & Co to identify new antibacterial drug candidates.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice